Experienced in Calcium Pyrophosphate Arthritis

Kei Ikeda

Tochigi, JP 
Experienced in Calcium Pyrophosphate Arthritis
Tochigi, JP 
OverviewLocationsClinical Research

Overview

Kei Ikeda practices in Tochigi, Japan. Ikeda is rated as an Experienced expert by MediFind in the treatment of Calcium Pyrophosphate Arthritis. Their top areas of expertise are Synovitis, Tenosynovitis, Rheumatoid Arthritis (RA), and Blau Syndrome.

Their clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Calcium Pyrophosphate Arthritis.

Locations

Tochigi, Japan
Other Locations
Yokohama, 2278502, Japan
Chiba, Japan
Mibu, Japan
Nishi, 8190395, Japan
Chuo, 2608670, Japan
Osaka, Japan
Fukuoka, 8190395, Japan
Japan
Asahi, 5458585, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Low-dose Glucocorticoids Plus Rituximab Versus High-dose Glucocorticoids Plus Rituximab for Remission Induction in ANCA-associated Vasculitis; a Multicentre, Open Label, Randomised Control Trial
Enrollment Status: Unknown
Publish Date: January 27, 2021
Intervention Type: Drug
Study Drugs: Rituximab, Glucocorticoids
Study Phase: Phase 4

136 Total Publications

Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective study.
Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective study.
Journal: Immunological medicine
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ikeda's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile